WIRE LIVE·0 active tenders·+0 added today·National Treasury OCDS · synced , ·
ProTenders.

Immunomodulating drugs

Mpumalanga · FY 2025/26

The market for immunomodulating drugs in Mpumalanga is worth about R70 million, which is a decent size. However, it's not growing, with zero year-on-year growth, so you'll need to compete for existing business. It's also a relatively uncrowded market, with only one supplier currently active, which could be a favourable opportunity for your organisation. The Department of Health in Mpumalanga is allocating about 44% of its budget to black-owned businesses, so if your business has a good black economic empowerment programme, you may have a competitive advantage. If I were you, I'd look into getting your B-BBEE level certified to take advantage of this allocation and try to get a foothold in this market.

Market Size

R70M

Suppliers

1

Departments

1

Avg Transaction

R23M

Supplier Type Allocation

EME (< R10M)

0%

QSE (R10-50M)

0%

GE (> R50M)

0%

BEE Allocation

Black Owned

44.1%

Women Owned

6.1%

Youth Owned

0.7%

Disabled Owned

0.3%

Spending Trend

2018/19
R433K
2019/20
R16K
2020/21
R73K
2021/22
R90M
2022/23
R62M
2023/24
R21M
2024/25
R39M
2025/26
R70M
View national Immunomodulating drugs market →View all Mpumalanga procurement →
Stop checking 14 portals. Start winning.

Your next contract is on the wire. Find it in five minutes.

Free to browse. Free alerts. No credit card. Built by South African SMMEs for South African SMMEs.

Browse all tenders →Set up free alerts
Wire liveOCDS-compliantPOPIA-alignedCape Town · Johannesburg